aristolochic acid i has been researched along with Adenocarcinoma Of Kidney in 6 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clear cell renal cell carcinoma (ccRCC) is a heterogeneous disease with features that vary by ethnicity." | 1.56 | Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. ( Bai, F; Dong, J; Dong, ZH; Ge, LY; George Rozen, S; Li, RY; Lu, M; Lu, Y; Luo, GD; Ma, LL; Ma, RZ; Song, YM; Wang, GL; Wang, SY; Wang, X; Wang, XM; Wu, D; Zhang, SD, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, XM | 1 |
| Lu, Y | 1 |
| Song, YM | 1 |
| Dong, J | 1 |
| Li, RY | 1 |
| Wang, GL | 1 |
| Wang, X | 1 |
| Zhang, SD | 1 |
| Dong, ZH | 1 |
| Lu, M | 1 |
| Wang, SY | 1 |
| Ge, LY | 1 |
| Luo, GD | 1 |
| Ma, RZ | 1 |
| George Rozen, S | 1 |
| Bai, F | 1 |
| Wu, D | 1 |
| Ma, LL | 1 |
| Jelaković, B | 1 |
| Castells, X | 1 |
| Tomić, K | 1 |
| Ardin, M | 1 |
| Karanović, S | 1 |
| Zavadil, J | 2 |
| Turesky, RJ | 3 |
| Yun, BH | 2 |
| Brennan, P | 1 |
| Mates, D | 1 |
| Jinga, V | 1 |
| Harnden, P | 1 |
| Banks, RE | 1 |
| Blanche, H | 1 |
| Bihoreau, MT | 1 |
| Chopard, P | 1 |
| Letourneau, L | 1 |
| Lathrop, GM | 1 |
| Scelo, G | 1 |
| Hoang, ML | 1 |
| Chen, CH | 2 |
| Chen, PC | 1 |
| Roberts, NJ | 1 |
| Dickman, KG | 2 |
| Pu, YS | 2 |
| Vogelstein, B | 1 |
| Papadopoulos, N | 1 |
| Grollman, AP | 2 |
| Kinzler, KW | 1 |
| Rosenquist, TA | 1 |
| Moriya, M | 1 |
| Sidorenko, VS | 1 |
| Edwards, KL | 1 |
| Gnatenko, DV | 1 |
| Wu, L | 1 |
| Wu, XR | 1 |
| Schetter, AJ | 1 |
| Harris, CC | 1 |
6 other studies available for aristolochic acid i and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Asian People; Carcinoma, Renal Cell; China; Coho | 2020 |
Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Topics: Adult; Aged; Aristolochic Acids; Balkan Nephropathy; Carcinogens; Carcinoma, Renal Cell; Exome; Fema | 2015 |
Aristolochic acid exposure in Romania and implications for renal cell carcinoma.
Topics: Aristolochic Acids; Carcinoma, Renal Cell; Deoxyadenosines; Humans; Kidney Neoplasms; Mutation; Roma | 2016 |
Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinogens; Carcinoma, Renal Cell; Case-Control | 2016 |
Aristolochic acid-associated urothelial cancer in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional C | 2012 |
Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome.
Topics: Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Fema | 2012 |